aod9604 peptide mechanism of action AOD 9604: Claims vs Clinical Reality AOD 9604 is marketed as a fat-metabolism peptide derived from a growth hormone fragment, often positioned as “HGH-like” without HGH's side effects. The clinical question AOD9604

GLP-1 medications (1522.5% body weight loss) are significantly more effective than phentermine (57%) over longer treatment courses

Side Effect Profiles TB-500 side effects: Head rush feeling post-injection (minutes) Temporary fatigue Increased hunger (some users) Hair growth (wanted or unwanted) Minimal serious concerns reported BPC-157 side effects: Essentially none reported commonly Theoretical cancer risk (unproven) Some report vivid dreams Rare headaches Both have excellent safety profiles in practice, though long-term data absent

specifically, semaglutide is a GLP-1 receptor agonist with 94% sequence homology to human GLP-1

And, certainly, continue the traditional therapies